medigraphic.com

2022, Number 3

<< Back Next >>

Rev Fac Med UNAM 2022; 65 (3)

Six Cases of Reports of Eclampsia in a Rural Hospital from the Chiapas Jungle

Arriaga LA, Álvarez TA, Meléndez CS, Vera SMD, Quintero GAB

Language: Spanish
References: 22
Page: 24-32
PDF size: 177.01 Kb.


ABSTRACT

Eclampsia is a relatively rare and unpredictable syndrome of pregnancy-induced hypertensive disease, characterized by a tonic-clonic seizure state which may or may not present hypertension or end-organ damage. It complicates approximately 3 out of 1000 pregnancies, with a high incidence in patients of low socioeconomic status and rural areas, women with pre-eclampsia, primiparous teen or multipa rous women over 35 years old. We present the report of 6 cases of eclampsia that occurred in a first level rural hospital of attention in the state of Chiapas, located in the heart of the Lacandon Jungle. Most of them occurred in primiparous teen patients during labor, which exceeded 40 weeks of gestation. All were promptly managed with support measures and magnesium sulfate neuroprotection, 5 of them referred to the second level of the intensive care unit for more comprehensive care, the average length of stay was 2 days. No one presented a new seizure. No adverse perinatal outcomes or maternal death were recorded. The pre-eclampsia- eclampsia syndrome is a problem with a high impact on pregnancy and a challenge for all three levels of care, but especially for care in rural areas and indigenous areas throughout Mexico, since, due to entrenched customs, patients omit prenatal control, in addition to living in places with difficult access to hospitals or clinics.


REFERENCES

  1. Sánchez E, Gómez J, Morales V. Preeclampsia severa, eclampsia,síndrome de HELLP, comportamiento clínico. Rev FacMed UNAM. 2005;48:145-50.

  2. Norma Oficial Mexicana NOM-007-SSA2-2016, Para laatención de la mujer durante el embarazo, parto y puerperio,y de la persona recién nacida. [Consultado: 10 deenero de 2022]. Disponible en: https://www.cndh.org.mx/documento/nom-007-ssa2-2016-atencion-de-la-mujerdurante-el-embarazo-parto-y-puerperio-y-de-la-personarecien-nacida.pdf

  3. Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M,Vogel JP, et al. Preeclampsia, eclampsia and adverse maternaland perinatal outcomes: a secondary analysis ofthe World Health Organization Multicountry Survey onMaternal and Newborn Health. BJOG. 2014;121(1):14-24.doi:10.1111/1471-0528.12629

  4. Centro Nacional de Excelencia Tecnológica en Salud. Guíade Práctica Clínica. Prevención, diagnóstico y tratamientode la Preeclampsia en segundo y tercer nivel de atención,Secretaría de Salud, México, 2017. [Consultado: 10 deenero de 2022]. Disponible en: https://www.imss.gob.mx/sites/all/statics/guiasclinicas/020GER.pdf

  5. Rojas M. Manejo de las convulsiones eclámpticas. RevMed Costa Rica. 2015;616:545-50.

  6. Informes Semanales para la Vigilancia Epidemiológica deMuertes Maternas 2021. Secretaría de Salud. [Consultado:10 de enero de 2022]. Disponible en: https://www.gob.mx/salud/documentos/informes-semanales-para-la-vigilanciaepidemiologica-de-muertes-maternas-2021

  7. Espinoza J, Vidaeff A, Pettker C.M, Simhan H. GestationalHypertension and Preeclampsia. ACOG PracticeBulletin 202. 2019;133(1):2-25.

  8. Vázquez D, Domínguez A, Cortés DK, Francisco J. Eclampsiay síndrome HELLP completo: el extremo de la complicaciónobstétrica. Med Int Mex. 2013;29:424-30.

  9. Guidelines and Audit Committee of the Royal College ofObstetricians and Gynecologists. Guideline No. 10(A).The management of severe pre-eclampsia/eclampsia.2010;2-8.

  10. Altman D, Carroli G, Duley L, Farrell B, Moodley J,Neilson J, et al. Do women with preeclampsia, and theirbabies, benefit from magnesium sulphate? The MagpieTrial: a randomized placebo-controlled trial. Magpie TrialCollaboration Group. Lancet 2002;359(9321):1877-90.doi:10.106 /s0140-6736(02)08778-0.

  11. Coetzee EJ, Dommisse J, Anthony J. A randomized controlledtrial of intravenous magnesium sulphate versusplacebo in the management of women with severe preeclampsia.Br J Obstet Gynaecol. 1998;105(3):300-3. doi:10.1111/j.1471-0528.1998.tb10090.x.

  12. Sibai B. Diagnosis, prevention, and management of eclampsia.Obstet Gynecol. 2005;105:402-10. doi: 10.1097/01.AOG.0000152351.13671.99

  13. Douglas KA, Redman CW. Eclampsia in the UnitedKingdom. BMJ. 1994;309:1395-400. doi: 10.1136/bmj.309.6966.1395.

  14. NICE clinical guidelines 133: Hypertension in pregnancy:diagnosis and management. National Institute for Healthand Care Excellence. 2019;6-49.

  15. Montiel D, Nuñez A, Moran A. Adolescente gestante coninfarto agudo de miocardio sin elevación del segmentoST como complicación de una eclampsia. Rev virtualSoc Parag Med Int. 2014;1(2):54-60. doi: 10.18004/rvspmi/2312-3893.

  16. Knight M. Eclampsia in the United Kingdom in 2005.BJOG. 2007;114(9):1072-78. doi: 10.1111/j.1471-0528.2007.01423.x.

  17. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, WangA, et al. A reversible posterior leukoencephalopathy syndrome.N Engl J Med. 1996;334(8):494-500. doi: 10.1056/NEJM199602223340803.

  18. Noraihan M, Sharda P, Jammal A. Report of 50 cases ofeclampsia. J Obstet Gynaecol Res. 2005;31(4):302-9. doi:10.1111/j.1447-0756.2005.00292.x.

  19. Reiley J, Moss H, Gibson J. Audit of management of eclampsiaand severe pre-eclampsia against RCOG standards.Arch Dis Child Fetal Neonatal. 2017;96(1):117-22.doi: 10.1136/adc.2011.300163.68.

  20. Duley L. Which anticonvulsant for wom en with eclampsia?Evidence from the Collaborative Eclampsia Trial.Lancet. 1995;345(8963):1455-63. doi: 10.1016/S0140-6736(95)91034-4.

  21. Urquiza F, Hernández JA. Estudios de imagen cerebralen el diagnóstico diferencial de enfermedades hipertensivasdel embarazo y convulsiones. Reporte de dos casos.Ginecol Obstet Mex. 2020;88(4):261-70. doi: 10.24245/gom.v88i4.3630.

  22. Hernández S, Gómez D, Bellart J, Peguero A, Mazarico E,Figueras F, et al. Protocolo: Hipertensión y gestación. 2017,4a ed. Barcelona, España: Hospital Clinic, Universitat deBarcelona, pp.1-23.




2020     |     www.medigraphic.com